Rheumatoid Arthritis Linked to Comorbidities Before, After Diagnosis
Increased odds of inflammatory bowel disease, type 1 diabetes, VTE seen before RA diagnosis versus controls
Read MoreNov 20, 2019
Increased odds of inflammatory bowel disease, type 1 diabetes, VTE seen before RA diagnosis versus controls
Read MoreNov 20, 2019
Increased odds of inflammatory bowel disease, type 1 diabetes, VTE seen before RA diagnosis versus controls
Read MoreNov 18, 2019
The 83rd Annual Meeting of the American College of Rheumatology The annual meeting of the American College of Rheumatology was held from Nov. 8 to 13 in Atlanta and attracted approximately 17,000 participants from around the world, including rheumatology specialists, physicians, scientists, and other health care professionals. The conference featured presentations focusing on the latest […]
Read MoreNov 18, 2019
The 83rd Annual Meeting of the American College of Rheumatology The annual meeting of the American College of Rheumatology was held from Nov. 8 to 13 in Atlanta and attracted approximately 17,000 participants from around the world, including rheumatology specialists, physicians, scientists, and other health care professionals. The conference featured presentations focusing on the latest […]
Read MoreNov 15, 2019
Contraceptive use among women of reproductive age with rheumatic diseases appears to be low....
Read MoreNov 12, 2019
Opioids have no impact on QoL or depression; smaller benefits seen for pain for strong versus weak opioids
Read MoreNov 12, 2019
Pustular psoriasis linked to arthritis onset two years earlier; increased delay seen for plaque psoriasis
Read MoreNov 11, 2019
New research and recommendations were presented at ACR 2019, The American College of...
Read MoreNov 11, 2019
Previous research indicates that patients with rheumatoid arthritis (RA) are at increased risk of...
Read MoreNov 4, 2019
More active inflammation, high ApoB/ApoA1 ratio, and homocysteine tied to coronary calcium risk
Read MoreNov 1, 2019
Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Common Sites of Bone Erosion in Rheumatoid Arthritis […]
Read MoreOct 31, 2019
“There is a well-recognized, unmet need for a new disease activity measure for systemic lupus...
Read MoreOct 31, 2019
Five sites most often showing bone erosion were wrist joint, big toe, thumb, index finger, middle finger
Read MoreSep 27, 2019
Meat, fish intake patterns among psoriasis patients in Japan opposite of those in Western countries
Read MoreSep 26, 2019
Low BMD, high bone metabolism, low vitamin D also seen in postmenopausal rheumatoid arthritis patients
Read MoreSep 24, 2019
New research and recommendations were presented at ASBMR 2019, the American Society for Bone and...
Read MoreSep 23, 2019
Asthma and allergies may be associated with increased risk of rheumatoid arthritis (RA), but...
Read MoreSep 17, 2019
Access issues include getting specialty appointments and affording treatment
Read MoreSep 11, 2019
Odds higher for HS patients with advancing age, ever smoking, history of depression, comorbidity
Read MoreAug 28, 2019
TNFi recommended over secukinumab, ixekizumab for AS and nonradiographic axial SpA as first biologic
Read More